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Quantitative polymerase chain reaction is essen-
tial in diagnosing and monitoring cytomegalo-
virus endotheliitis. Treatment with long-term
anti-virals and endothelial surgery can offer suc-
cessful visual rehabilitation.
Case Report
A 68-year-old British-Chinese gentleman with left
ocular hypertension was referred to the inﬂamma-
tory eye diseases clinic with a presumed left kera-
touveitis that developed six weeks after
uneventfulphacoemulsiﬁcationsurgerywithintra-
ocular lens implantation. This had failed to resolve
with oc. aciclovir 3% and intensive g. dexametha-
sone 0.1%. His left vision was 20/60, associated
with dense corneal stromal edema (Figure 1a),
keratic precipitates (KPs) (Figure 1b), mild anterior
chamberinﬂammation,andanintraocularpressure
(IOP) of 23mmHg. The posterior segment
appearedhealthywithnoevidenceofvitritis,chor-
oiditis or retinitis, and a normal optic disc.
An infectious etiology was suspected and a
diagnostic multiplex quantitative polymerase
chain reaction (qPCR) analysis of an aqueous
humor (AqH) sample taken at the slit-lamp
conﬁrmed left corneal endotheliitis secondary to
cytomegalovirus (CMV) (CMV, 150,000 DNA
copies/ml; Epstein-Barr virus [EBV], weakly
positive; and negative for herpes simplex virus,
varicella zoster virus, fungal 18S-rRNA, and
bacterial-16S rRNA). EBV DNAwas also detected
in whole blood. The patient was commenced on
oral valganciclovir 900 mg b.i.d. for 21 days fol-
lowed by 450 mg b.i.d. and non-preserved
g. dexamethasone 0.1% qid for three months.
Initialimprovementinhisclinicalconditionwas
supported by repeat whole blood and AqH qPCR
detecting only EBV DNA (whole-blood 3,700
copies/ml, AqH 17,600 copies/ml). Although
95% of adults worldwide are believed to have ser-
ological evidence of EBV infection, intraocular
EBV is strongly associated with central nervous
system lymphoma in AIDS.
1 A haematological
opinion was thus sought and excluded systemic
lymphoma.
Interruption of valganciclovir treatment (due to
non-availability in the community), resulted in an
acute re-presentation with a severely painful left
eye and reduced vision of hand movements at
30 cm. Examination revealed inferior haemorrha-
gicanteriorscleritis(Figure1c),abullouskeratopa-
thy, and inferior KPs consistent with a diagnosis
of recurrent CMV endotheliitis and associated
scleritis, conﬁrmed by qPCR of the AqH detecting
CMV DNA (1800 copies/ml). IOP was 28 mmHg
and fundal examination was normal. The patient
was commenced on intravenous ganciclovir
500 mgoncedailyfor14daysswitchingtooralval-
ganciclovir 900 mg b.i.d. for 21 days followed by a
maintenance dose of 900 mg once daily, ﬂurbipro-
fen 100 mg thrice daily for one month and inten-
sive non-preserved g.dexamethasone 0.1%.
Within one week there were signiﬁcant improve-
ments in the endotheliitis and scleritis, and by
four weeks, only mild corneal decompensation
and endothelial pigmentation remained (ventral
aortic 20/30).
Oral valganciclovir was discontinued after six
months following a negative AqH qPCR for CMV
DNA. Nevertheless, after continued progression
of corneal endothelial dysfunction (endothelial
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1cell count of 386/mm
2) and concomitant declining
visual acuity (6/200), the patient underwent an
8 mmDescemet’sstrippingautomatedendothelial
keratoplasty with concurrent implementation of
strict perioperative management strategies sum-
marized in Figure 2. An intraoperative AqH
sample and the stripped endothelium were nega-
tive for CMV, EBV, herpes simplex virus, varicella
zoster virus DNA. Four weeks postoperatively,
vision improved to 20/30, the corneal edema had
resolved (Figure 1d) and IOP was maintained at
14 mmHg. By seven months follow up, all topical
and systemic therapy had been discontinued, and
the cornea remained clear without further relapses
of endotheliitis.
Discussion
CMV is a β-herpesvirus detected in the serum of
45%–100% of the population worldwide.
2 Primary
infection is usually asymptomatic in the immuno-
competent but can have serious implications for
immunocompromised hosts.
1 Innate immune
mechanisms are important for ﬁrst-line defense,
butthevirusdemonstrateslatencythroughanadap-
tive T-cell response involving primarily effector
memory cytotoxic CD8+T-cells.
3 Breaches of the
normal immunoprotective ocular microenviron-
ment e.g. through surgical trauma results in acti-
vation of disease. Ocular involvement in the form
ofendotheliitis,anterioruveitis,
4Fuch’sheterochro-
mic iridocyclitis
5 and Posner-Schlossman syn-
drome
5 are recognized entities. CMV endotheliitis
is rare with all currently documented cases
restricted geographically to the Asia-Paciﬁc where
CMV is prevalent amongst the population.
6
CMV endotheliitis may present as a primary
endotheliitis
4 or in conjunction with a recurrent
anterior uveitis.
4 It has frequently been reported
following ocular surgery including Descemet’s
stripping automated endothelial keratoplasty.
7
Endotheliitis is characterized by the presence of
KPs, Descemet’s membrane folds and corneal
oedema conﬁgured in a disciform or sectoral
pattern,
4 often accompanied by a mild anterior
uveitis and/or ocular hypertension.
4 It can also
present as corneal oedema and Descemet’s mem-
brane folds in the absence of KPs.
4 The differential
diagnoses include postoperative corneal decom-
pensation, acutely raised IOP (trabeculitis,
Posner-Schlossman syndrome), or inﬂammation
(due to retained soft lens matter), herpes simplex
virus/varicella zoster virus keratouveitis or
Fuch’s heterochromic iridocyclitis).
CMV endotheliitis was ﬁrst described in 2006
4
inaJapanesepatientwhohadCMVDNAdetected
in the AqH. Distinctive owl’s eye morphological
cellular changes typical of CMV were sub-
sequently identiﬁed in vivo using corneal endo-
thelial confocal microscopy in another affected
patient.
4 The detection of CMV DNA in the AqH
is vital forassisting the diagnosis, and has particu-
lar implications for therapeutic intervention. CMV
responds poorly to systemic and topical aciclovir
(as exempliﬁed by our patient), but can be treated
successfully with oral valganciclovir,
7,8 or with
intravenous and topical ganciclovir.
4 Recent
studies utilizing qPCR have demonstrated a
signiﬁcant relationship between AqH CMV load
and rate of endothelial cell loss.
8 Treatment with
antiviral therapy also results in a decreased AqH
viral load.
9 Serial AqH sampling, therefore, rep-
resents a useful tool for quantifying the severity
Figure 1
Photograph of the left eye at presentation with the patient seeing
20/60 showing dense corneal stromal oedema (A) and multiple
keratic precipitates (B – arrowed). The patient re-presented after
interruption of oral valganciclovir treatment with a visual acuity of
hand movements at 30cm associated with severe anterior scleritis
accompanied by a relapse of CMV endotheliitis (C). Progressive
endothelial failure was successfully treated with DSAEK (D)
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Sudeshna PatraFigure 2
Strategies for the management and prevention of relapse of CMV endotheliitis.
4,7–9
Evidence-based therapeutic algorithm to manage acute manifestations and relapses with or without
associated scleritis and sclerokeratitis is illustrated. Implementation of a strict perioperative regime is
recommended for any planned intraocular surgical procedure to optimize visual outcome and minimize
the risk of surgically induced CMV endotheliitis and sclerokeratitis. Conﬁrmatory qPCR of AqH should be
performed, and if corneal transplant surgery is undertaken, excised host endothelium or penetrating
keratoplasty tissue should be analysed by qPCR, histopathology and immunoﬂuorescence studies for
evidence of active CMV infection i.e. characteristic ‘owl’se y e s ’.
(AqH, aqueous humour; qPCR, quantitative PCR; CMV, cytomegalovirus;)
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3of the disease and for monitoring response to
therapy not only for CMV endotheliitis, but also
for CMVassociated scleritis.
Our patient developed severe endotheliitis and
represents the ﬁrst reported case of secondary
haemorrhagic scleritis following abrupt cessation
of valganciclovir. This was highly responsive to
intravenous ganciclovir, oral ﬂurbiprofen and
intensive topical glucocorticoids, followed by
maintenance on oral valganciclovir obtaining
complete remission, but with secondary, clinically
signiﬁcant, irreversible corneal endothelial dys-
function. This was treated successfully with
small-incision, selective endothelial corneal trans-
plant surgery accompanied by a strict evidence-
based protocol to minimize surgically-induced
exacerbations/recurrence of disease (Figure 2).
10,11
CMV endotheliitis can be a difﬁcult condition
to treat and is often triggered by intraocular
surgery. We have suggested a treatment algorithm
that can be followed for resistant cases or if further
intraocular surgery is contemplated.
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